Comparison
5p Partial Monosomy Syndrome C0010314 vs 17 Alpha Hydroxylase 7 20 Lyase Deficiency Cn380063
Clinical comparison between 5P Partial Monosomy Syndrome and 17 Alpha Hydroxylase 7 20 Lyase Deficiency CN380063 for differential diagnosis and treatment planning.
5p Partial Monosomy Syndrome C0010314
Also called Cri-du-chat syndrome, caused by a deletion on chromosome 5. Features include a high-pitched cry, developmental delay, and intellectual disability.
17 Alpha Hydroxylase 7 20 Lyase Deficiency Cn380063
A rare genetic disorder affecting steroid hormone production. Causes ambiguous genitalia, lack of puberty, and high blood pressure. Requires lifelong hormone replacement therapy.
6 comparison axes
Onset
5p Partial Monosomy Syndrome C0010314
0-0
17 Alpha Hydroxylase 7 20 Lyase Deficiency Cn380063
0-18
Onset patterns differ
Severity
5p Partial Monosomy Syndrome C0010314
severe
17 Alpha Hydroxylase 7 20 Lyase Deficiency Cn380063
severe
Different severity levels
Chronic
5p Partial Monosomy Syndrome C0010314
Chronic
17 Alpha Hydroxylase 7 20 Lyase Deficiency Cn380063
Chronic
Differing course
Communicable
5p Partial Monosomy Syndrome C0010314
No
17 Alpha Hydroxylase 7 20 Lyase Deficiency Cn380063
No
Different transmission
Body System
5p Partial Monosomy Syndrome C0010314
congenital
17 Alpha Hydroxylase 7 20 Lyase Deficiency Cn380063
endocrine
Same/different system
Category
5p Partial Monosomy Syndrome C0010314
genetic
17 Alpha Hydroxylase 7 20 Lyase Deficiency Cn380063
endocrine
Different category
Bottom line
5p-partial-monosomy-syndrome-C0010314 and 17-alpha-hydroxylase-7-20-lyase-deficiency-CN380063 differ in etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 5p Partial Monosomy Syndrome C0010314 | 17 Alpha Hydroxylase 7 20 Lyase Deficiency Cn380063 | Discriminating power |
|---|---|---|---|
| Infant cry | High-pitched cry is a described feature. | Not described as a characteristic feature. | High |
| Development | Developmental delay and intellectual disability are described. | Primary description concerns hormones, puberty, and blood pressure. | High |
| Sexual development and blood pressure | Not described as the main presentation. | Ambiguous genitalia, absent puberty, and hypertension are described. | High |
When to favor each condition
Choose 5p Partial Monosomy Syndrome C0010314 when
Newborn with characteristic cry and developmental concern
Fits the supplied congenital chromosomal phenotype better than an endocrine steroid disorder.
Moderate
Suspected chromosome 5 deletion
The condition is defined by partial monosomy of chromosome 5.
High
Congenital multisystem developmental presentation
Onset is listed at birth and the body-system category is congenital.
Moderate
Choose 17 Alpha Hydroxylase 7 20 Lyase Deficiency Cn380063 when
Ambiguous genitalia with absent puberty
These features are specifically supplied for the steroid disorder.
Moderate
Hypertension with suspected steroid imbalance
High blood pressure and impaired steroid production are described.
Moderate
Presentation from birth through adolescence
Supplied onset spans 0–18 years rather than birth only.
Low
How key tests differ
| Test | 5p Partial Monosomy Syndrome C0010314 | 17 Alpha Hydroxylase 7 20 Lyase Deficiency Cn380063 | Interpretation |
|---|---|---|---|
| Chromosomal analysis | May identify a chromosome 5 deletion. | Not the defining test in the supplied description. | A chromosomal result supports, but does not by itself exclude, other diagnoses. |
| Steroid hormone evaluation | No characteristic steroid pattern is supplied. | Abnormal steroid production is expected, without specified cutoffs. | Interpret results clinically; an abnormal panel is not automatically this diagnosis. |
| Disorder-specific genetic testing | May confirm the chromosomal deletion. | May support the suspected enzyme deficiency when clinically indicated. | Testing choice should follow phenotype; exact method is not established here. |
Prognosis comparison
5p Partial Monosomy Syndrome C0010314
- Outcome
- Chronic congenital condition with developmental effects; exact prognosis is not established here.
- Factors
- Deletion extent, developmental support, and associated complications may influence outcome.
17 Alpha Hydroxylase 7 20 Lyase Deficiency Cn380063
- Outcome
- Chronic endocrine condition requiring lifelong hormone care; mortality is not supplied.
- Factors
- Blood-pressure control, puberty management, and treatment adherence may matter.
Time frame: Lifelong for both; onset differs from birth versus birth through adolescence.
Comparative outcomes are not established and require clinician interpretation.
Complications comparison
| Complication | Presentation |
|---|---|
| Neurodevelopment | Developmental delay and intellectual disability may persist. Not established as a primary feature from supplied data. Severity and functional outcome vary and need clinician assessment. |
| Blood pressure | Hypertension is not a supplied defining feature. High blood pressure is described. Monitoring is appropriate, but targets are not specified here. |
| Hormone deficiency | Lifelong hormone replacement is not described. Lifelong hormone replacement is stated as required. Doses and regimens must be individualized and are not provided. |
Patient education highlights
- HighDifferent causes
One involves missing chromosome 5 material; the other impairs steroid hormone production.
- HighSpecialist care
Genetics, developmental, and endocrine specialists should guide testing and treatment.
- MediumNot contagious
Neither condition is described as communicable.